Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation. (2021)
Attributed to:
Defining the role of FOSL2 in molecular adaptation to hypoxia in colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ph14090852
PubMed Identifier: 34577552
Publication URI: http://europepmc.org/abstract/MED/34577552
Type: Journal Article/Review
Volume: 14
Parent Publication: Pharmaceuticals (Basel, Switzerland)
Issue: 9
ISSN: 1424-8247